Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
08/11/2011 | US20110195021 Cd20 antibodies and uses thereof |
08/11/2011 | US20110195019 Nucleic acids and corresponding proteins entitled 251p5g2 useful in treatment and detection of cancer |
08/11/2011 | CA2789154A1 Common light chain mouse |
08/11/2011 | CA2788993A1 Peptides capable of binding to serum albumin and compounds, constructs and polypeptides comprising the same |
08/11/2011 | CA2788967A1 Process for obtaining antibodies |
08/11/2011 | CA2788720A1 Medicament for treating and/or preventing cancer |
08/11/2011 | CA2788718A1 Pharmaceutical composition for treating and/or preventing cancer |
08/11/2011 | CA2788716A1 Pharmaceutical composition for treating and/or preventing cancer |
08/11/2011 | CA2788715A1 Pharmaceutical composition for treating and/or preventing cancer |
08/11/2011 | CA2788547A1 Pharmaceutical composition for treating and/or preventing cancer |
08/11/2011 | CA2788545A1 Pharmaceutical composition for treating and/or preventing cancer |
08/11/2011 | CA2786337A1 A monoclonal antibody to cd44 for use in the treatment of head and neck squamous cell carcinoma |
08/10/2011 | EP2354791A1 Immunocytokines with modulated selectivity |
08/10/2011 | EP2354230A1 Neisseria meningitidis surface protein |
08/10/2011 | EP2354164A1 Anti-NIK antibodies and uses thereof |
08/10/2011 | EP2354163A2 Conjugates of duocarmycin and anti-CD70 or anti-PSMA antibodies |
08/10/2011 | EP2354162A1 Anti-CD3 antibody formulations |
08/10/2011 | EP2354161A1 Anti-nr10 antibody, and use thereof |
08/10/2011 | EP2354160A1 Engineered anti-IL-23-antibodies |
08/10/2011 | EP2354159A1 CCL17 inhibitors for use in T helper cell-driven diseases |
08/10/2011 | EP2354158A1 Enigma-Mdm2 interaction and uses thereof |
08/10/2011 | EP2354149A1 Molecules with extended half-lives, compositions and uses thereof |
08/10/2011 | EP2353615A2 Compositions and methods for treating inflammatory lung disease |
08/10/2011 | EP2353613A1 Zolpidem immunoassay with extended detection window |
08/10/2011 | EP2353611A2 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
08/10/2011 | EP2353009A2 Use of isolated polypeptides having antigenic properties against mycoplasma pneumoniae, and of corresponding polynucleotides and antibodies |
08/10/2011 | EP2353004A2 Diagnosis of multiple sclerosis |
08/10/2011 | EP2352766A1 Nanoaggregate embedded beads conjugated to single domain antibodies |
08/10/2011 | EP2352765A2 Cross-species-specific single domain bispecific single chain antibody |
08/10/2011 | EP2352764A2 Amino acid sequences targeting human cd4, cxcr4, ccr5, tlr4, alphav integrin, beta3-integrin,beta1-integrin, human alpha2-integrin, cd81, sr-bi, claudin-1, claudin-6 and claudin-9, respectively, and neutralizing viral entry |
08/10/2011 | EP2352763A2 Bispecific single chain antibodies with specificity for high molecular weight target antigens |
08/10/2011 | EP2352762A1 Inflammatory bowel disease biomarkers and related methods of treatment |
08/10/2011 | EP2352761A2 Inhibition of plgf to treat philadelphia chromosome positive leukemia |
08/10/2011 | EP2352760A2 Methods and vectors for display of 2g12-derived domain exchanged antibodies |
08/10/2011 | EP2352759A2 Human cytomegalovirus neutralizing antibodies and use thereof |
08/10/2011 | EP2352758A2 Single chain antibody library design |
08/10/2011 | EP2352523A1 Improved anti-cd19 antibodies |
08/10/2011 | EP2352522A1 Bispecific intracellular delivery vehicles |
08/10/2011 | EP2352521A1 Immunoglobulin variants and uses thereof |
08/10/2011 | EP2352517A1 Methods and compositions for treating complement-associated disorders |
08/10/2011 | EP2352516A2 Immunization of avians by mucosal administration of non-replicating vectored vaccines |
08/10/2011 | EP2352502A2 Limited proteolysis of cd2ap and progression of renal disease |
08/10/2011 | EP1709073B1 SUBSTANCE BINDING HUMAN IgG Fc RECEPTOR IIb (FcgammaRIIb) |
08/10/2011 | EP1565581B1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
08/10/2011 | EP1461079B1 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
08/10/2011 | EP1438388B1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
08/10/2011 | EP1345967B1 Phage display libraries of human v h fragments |
08/10/2011 | EP1190074B1 Recombinant anti-cd40 antibody and uses thereof |
08/10/2011 | EP0935001B2 Novel vegf-like factors |
08/10/2011 | CN1817906B Antibody against human parathormone related peptides |
08/10/2011 | CN102149825A Prostaglandin E2 dual variable domain immunoglobulins and uses thereof |
08/10/2011 | CN102149730A FGF-R4 receptor-specific antagonists |
08/10/2011 | CN102149729A Antibodies against FcRn and use thereof |
08/10/2011 | CN102149728A Methods for inhibiting ocular angiogenesis |
08/10/2011 | CN102149727A Constructs and libraries comprising antibody surrogate kappa light chain sequences |
08/10/2011 | CN102149403A Methods of treatment utilizing binding proteins of the interleukin-21 receptor |
08/10/2011 | CN102146367A Method for detecting 14-3-3 protein in cerebrospinal fluid |
08/10/2011 | CN102146366A Method for detecting abnormal prion protein in brain tissue |
08/10/2011 | CN102146138A Monoclonal antibody to chloramphenicol and application thereof |
08/10/2011 | CN102146137A Antibody to beta-amyloid peptide and application thereof |
08/10/2011 | CN102146116A Preparation and detection methods for specific antiserum of mogroside V |
08/10/2011 | CN101514230B Monoclone antibody of ARD1 and application thereof |
08/10/2011 | CN101503472B Human source neutralizing antibody specific against botulinum neurotoxin type A and use thereof |
08/10/2011 | CN101333255B BP180 single chain antibody of humanized anti-bullous pemphigoid antigen and its use |
08/09/2011 | US7994301 Modulators of body weight, corresponding nucleic acids and proteins |
08/09/2011 | US7994299 Compositions and methods for increasing bone mineralization |
08/09/2011 | US7994294 Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase |
08/09/2011 | US7994293 Antibodies specific for Dkk-1 |
08/09/2011 | US7994292 MU-1, member of the cytokine receptor family |
08/09/2011 | US7994289 Humanized anti-CD3 antibodies |
08/09/2011 | US7994288 Allergenic proteins of natural rubber latex, their production and use in assays |
08/09/2011 | US7994287 Antibodies which bind human CXCR3 |
08/09/2011 | US7994286 Neuropilin antagonists |
08/09/2011 | US7994285 Transmembrane cell surface receptor specific immunoglobulin for use in diagnosis and treatment of cell proliferative, cardiovascular, arthritic and diabetic disorders |
08/09/2011 | US7994282 Card proteins involved in cell death regulation |
08/09/2011 | US7994135 Antibodies conjugated to Auristatin analogs via a maleimidocaproyl lingages; for treating cancer, autoimmune diseases and infectious diseases |
08/09/2011 | US7994128 Conotoxin peptides useful as inhibitors of neuronal amine transporters |
08/09/2011 | US7994116 Methods for reduction of adhesion formation using cytokine inhibitors |
08/09/2011 | US7993878 Antibodies to human IL-1β |
08/09/2011 | US7993864 Assay for identifying antibody producing cells |
08/09/2011 | US7993858 Methods for predicting pregnancy outcome in a subject by hCG assay |
08/09/2011 | US7993857 Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith |
08/09/2011 | US7993849 Human TIMP-1 antibodies |
08/09/2011 | US7993845 ACPL-related assays |
08/09/2011 | US7993834 Detection of ErbB2 gene amplification to increase the likelihood of the effectiveness of ErbB2 antibody breast cancer therapy |
08/09/2011 | US7993649 Hybridoma producing antibodies to Lawsonia intracellularis |
08/09/2011 | US7993647 Monoclonal antibodies to HIV-1 and methods of using same |
08/09/2011 | US7993644 Tissue factor antibodies and uses thereof |
08/09/2011 | US7993643 Using low density lipoprotein receptor specific immunoglobulin for treatment and prevention of athersclerotic, kidney and inflammatory disorders |
08/09/2011 | US7993642 Anti-MPL antibodies |
08/09/2011 | US7993641 Methods of treatment using anti-CD3 antibodies |
08/09/2011 | US7993627 Using immunoassy to screen moulators of brain protein expression in cells; treating Alzheimer's disease/brain disorders; drug screening |
08/09/2011 | CA2616940C Novel serine protease bssp2 |
08/09/2011 | CA2481731C Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/09/2011 | CA2380058C Novel peptides |
08/09/2011 | CA2370738C Uteroglobin in the treatment of iga mediated autoimmune disorders |
08/09/2011 | CA2367360C Insulin-like growth factor binding protein-4 protease |
08/09/2011 | CA2350340C B-cell epitopes of hsp65 and uses thereof |
08/09/2011 | CA2291721C Ribosome complexes as selection particles for in vitro display and evolution of proteins |
08/09/2011 | CA2267068C Renilla luciferase and green fluorescent protein fusion genes |